Q4 2020 Relmada Therapeutics Inc Earnings Call Transcript
Greetings. Welcome to the Relmada Therapeutics, Inc. Fourth Quarter and Full Year 2020 Financial Results Conference Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the call over to your host, Tim McCarthy. Please go ahead.
Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer; Dr. Sergio Traversa; Chief Financial Officer, Maged Shenouda; and Chief Accounting and Compliance Officer, Chuck Ence.
This afternoon, Relmada issued a news release providing a business update and announcing financial results for the fourth quarter and full year ended December 31, 2020.
Please note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Relmada's management team will be making forward-looking statements. Actual results could differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |